GLP-1 Weight-Loss Drugs (Ozempic, Wegovy, Mounjaro)?
Real-world feedback from users and medical professionals
Overall
16 responses.
GLP-1 weight-loss medications—including Ozempic, Wegovy, and Mounjaro—are rapidly transforming obesity and metabolic care. Clinical trials show strong results, but real-world experiences vary widely in effectiveness, side-effect severity, long-term sustainability, cost, and quality-of-life impact.
This PByT Hub captures the six most important questions that matter in assessing GLP-1 outcomes. Each question can be answered by both users and medical professionals, giving a global picture of real-world results.
Statement:
Based on my experience (or my patients’ experience), GLP-1 drugs have been effective for weight loss and appropriately safe. Agree/Disagree →
___
Additional Key Questions/Issues
How Severe Are GLP-1 Side Effects?
Overall Satisfaction With GLP-1 Treatment?
Concern About Long-Term Use of GLP-1 Drugs?
By age group
25-44
9 responses.
Over 64
7 responses.
By gender
Male
7 responses.
Female
9 responses.
By occupation
App Worker
2 responses.
White Collar - Staff
7 responses.
Professional - Private
7 responses.
By religion
Christianity
9 responses.
Buddhism
4 responses.
No religion
3 responses.
By location
Massachusetts, United States
9 responses.
Victoria, Australia
6 responses.
New South Wales, Australia
3 responses.
By country
United States
9 responses.
Australia
9 responses.
By federal electorate
Kooyong
6 responses.
Feedback by Australian federal electorates, where applicable.
Feedback ... (No Comments)
Please log in or join, in order to view or give feedback.